Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATRIC acute respiratory infection amoxicillin duration trial
ACTRN12621000967886Phase 4Terminated
- Sponsor
- Kids Research Institute Australia
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin in community-acquired pneumonia (CAP), pulmonary infection and acute respiratory illness (ARI) (4 arms), sponsored by Kids Research Institute Australia. Primary endpoint: Symptom resolution by day 7. Started Feb 2022; status: terminated.
02
Drugs
amoxicillin
03
Conditions
community-acquired pneumonia (CAP)pulmonary infectionacute respiratory illness (ARI)
Beyond the preview
Go deeper on ACTRN12621000967886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000967886.